Evidence map›Paper›PMID 16239557›Full record

ArticleInfection and immunity2005

Invariant NKT cells are essential for the regulation of hepatic CXCL10 gene expression during Leishmania donovani infection.

Mattias Svensson, Soombul Zubairi, Asher Maroof, Fatima Kazi, Masaru Taniguchi, Paul M Kaye

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Interferon gamma in leishmaniasis.Frontiers in immunology · 2013
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. NKT cell immune responses to viral infection.Expert opinion on therapeutic targets · 2009
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Mattias SvenssonImmunology and Infection Unit, Department of Biology, University of York, Heslington, York YO10 5YW, United Kingdom.
Soombul Zubairi
Asher Maroof
Fatima Kazi
Masaru Taniguchi
Paul M Kaye
University of London · GBLondon School of Hygiene & Tropical Medicine · GBRIKEN Center for Integrative Medical Sciences · JP

Funding

Wellcome Trust
6 · The paper itself

Abstract

Gamma interferon (IFN-gamma)-regulated chemokines of the CXC family have been implicated as key regulators of a variety of T-cell-dependent inflammatory processes. However, the cellular source(s) of IFN-gamma that regulates their early expression has rarely been defined. Here, we have directly addressed this question in mice after Leishmania donovani infection. Comparison of CXCL10 mRNA accumulation in normal and IFN-gamma-deficient mice confirmed an absolute requirement for IFN-gamma for sustained (24 h) expression of CXCL10 mRNA accumulation in this model. In normal mice, IFN-gamma was produced by both CD3int NK1.1+ NKT cells and CD3- NK1.1+ NK cells, as detected by intracellular flow cytometry. Strikingly, B6.Jalpha281-/- mice lacking NKT cells that express the invariant Valpha14Jalpha18 T-cell-receptor alpha chain, although retaining a significant population of IFN-gamma-producing NK cells and NKT cells, were unable to sustain CXCL10 mRNA accumulation. These data indicate that invariant NKT cells are indispensable for the regulation of hepatic CXCL10 gene expression during L. donovani infection.

Indexed as

Gene Expression RegulationLeishmania donovaniAnimalsChemokine CXCL10Chemokines, CXCInterferon-gammaKiller Cells, NaturalLeishmaniasis, VisceralLiverMiceMice, Inbred C57BLMice, KnockoutRNA, MessengerT-LymphocytesChemokine CXCL10Chemokines, CXCCxcl10 protein, mouseInterferon-gammaRNA, Messenger

Identifiers

PMID16239557
PMCPMC1273891
OpenAlexW2156886807

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.